We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Lassa virus causes Lassa fever, an acute viral haemorrhagic fever (VHF).
The indication for the treatment of post-operative pain has been removed from the licences of all prolonged release opioids due to the increased risk of persistent post-operative opioid use (PPOU) and opioid-induced ventilatory impairment (OIVI).
The characteristics, symptoms, diagnosis and epidemiology of chikungunya.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Crimean-Congo haemorrhagic fever (CCHF) is a viral haemorrhagic fever (VHF) caused by a virus of the Nairoviridae family.
Find out about the symptoms of COVID-19, what to do if you or your child has them and when to get medical help.
Find out about the long-term effects some people can have after having COVID-19.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).